Reuters logo
1 个月内
BRIEF-Aldeyra Therapeutics expects to report results from phase 2A trial of topical ocular ADX-102 late in Q3
2017年6月15日 / 晚上9点27分 / 1 个月内

BRIEF-Aldeyra Therapeutics expects to report results from phase 2A trial of topical ocular ADX-102 late in Q3

1 分钟阅读

June 15 (Reuters) - Aldeyra Therapeutics Inc:

* Aldeyra Therapeutics-expects to report results from phase 2a trial of topical ocular ADX-102 late in Q3, 2017, not early in Q3 as stated in conf call Source text: (bit.ly/2rBbbkk) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below